Myelin Autoantigens in Neuropathic Pain
神经性疼痛中的髓磷脂自身抗原
基本信息
- 批准号:9770829
- 负责人:
- 金额:$ 72.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAgonistAir MovementsAmyloid beta-ProteinAnalgesicsAnti-inflammatoryAntigen-Antibody ComplexAttenuatedAutoantigensAutoimmune DiseasesAutoimmune ProcessBehavioralBiochemicalBioinformaticsC FiberCalciumCalcium SignalingCollaborationsDataDevelopmentDiseaseElectrophysiology (science)EpitopesEstrogen ReceptorsEstrogensEventFemaleFiberFosteringFundingGap JunctionsHistidineHomingHyperalgesiaHypersensitivityIL6 geneITPR1 geneImmuneImmune responseImmunologic MonitoringImmunologic ReceptorsIn VitroInjectionsInjuryInnate Immune SystemInositolInterleukin-6InterneuronsIntracellular TransportLXRalpha proteinLightLinkLipidsLiverLiver X ReceptorMass Spectrum AnalysisMechanical StimulationMechanicsMediatingMembrane LipidsMembrane MicrodomainsMicrogliaMolecularMyelinMyelin Basic ProteinsMyelin SheathNerveNerve TissueNeuronsNociceptionPainPainlessPathologicPathway AnalysisPeptidesPersistent painPharmacologyPhenotypeProtein BiochemistryProteinsRanvier&aposs NodesRattusReceptor CellReceptor SignalingRefractoryResistanceReticulumRodentRoleSeminalSignal PathwaySignal TransductionSiteSpinalSpinal CordSpinal GangliaStimulusStressStructural ModelsT-LymphocyteTactileTestingTherapeuticTouch sensationTraumatic injuryVeronicaWorkX Chromosomeafferent nerveallodyniachronic constriction injurychronic painimprintin vivoinhibitor/antagonistinnovationmalemechanical allodyniamultidisciplinarymutantnerve injuryneuroinflammationneuronal cell bodynovelpainful neuropathypreventprogramsprotein foldingprotein kinase C gammareceptorsciatic nervesexual dimorphismsomatosensorytooltranscriptome sequencingtripolyphosphatevibration
项目摘要
We propose that pathological pain from innocuous mechanical stimulation such as light touch or slight air
movement (defined as mechanical allodynia) represents an autoimmune disorder in females. This conceptually
new view of this refractory chronic pain phenotype is the overarching thesis of our renewal application. Recent
seminal work implicates adaptive immune/T cells and innate immune system/microglia in the development of
mechanical allodynia in female and male rodents, respectively. However, the mechanisms of this sexual
dimorphism phenomenon are obscure. Our groundbreaking data suggests that a known auto-antigen, myelin
basic protein (MBP), holds the mechanistic key to sexual dimorphism in mechanical allodynia. We suggest that
any, including physical, damage to myelin sheath on mechanosensitive Aβ-afferent fibers results in proteolytic
liberation of cryptic MBP peptides normally sheltered from immunosurveillance. The peptide encoding the
central (84-104) region of MBP (MBP84-104) produces direct, robust and lasting hypersensitivity to light touch (Aβ
fiber-mediated) but not thermal (C fiber-mediated) stimulation. The conserved histidine (H)-89 site is required to
intracellular transport and the algesic activity of MBP84-104. Using biochemical and molecular tools, including
mass-spectrometry, RNA-sequencing, bioinformatics, structural modeling, and immunocapture of wildtype,
mutant and control peptides, combined with rigorous pharmacological, neuropathological, and behavioral
analyses, we identified a cluster of the MBP84-104 interactors and downstream signaling factors promoting in
females (and/or protecting males from) the development of allodynia. These MBP84-104-related leads with the
established roles in pain circuitry, such as the X-chromosome imprinted gene interleukin 6, are here linked to a
master-regulator of lipid, immune and estrogen receptor signaling pathways, liver X receptor, which is new to
the pain field. With our unique, accrued toolset and rigorous data obtained in a prolific collaboration among the
teams of the PI, Veronica Shubayev (UCSD) with Tony Yaksh (UCSD) and Alex Strongin (SBP), we aim to
identify the precise molecular events in nerve, dorsal root ganglia and spinal cord leading to the sexual
dimorphism in neuropathic pain. We expect our innovative findings will foster the development of conceptually
novel analgesic therapeutics useful in refractory types of chronic pain.
我们认为,由无害的机械刺激引起的病理性疼痛,如轻微的触摸或轻微的空气
运动(定义为机械性痛觉异常)代表女性的一种自身免疫性疾病。这在概念上是
对这种顽固性慢性疼痛表型的新观点是我们更新应用的首要论题。近期
开创性工作涉及获得性免疫/T细胞和先天性免疫系统/小胶质细胞在
雌性和雄性啮齿动物的机械性痛觉异常。然而,这种性行为的机制
二态现象比较隐晦。我们的突破性数据表明,一种已知的自身抗原,髓鞘
碱性蛋白(MBP)是机械性异位痛性二形性的机制关键。我们建议
机械敏感型Aβ传入纤维上的任何髓鞘损伤,包括物理损伤,都会导致蛋白分解
释放隐蔽的MBP多肽,通常不受免疫监视。编码该基因的多肽
MBP的中央(84-104)区域(MBP84-104)对光接触(Aβ)产生直接、强大和持久的超敏反应
纤维介导),而不是热(C纤维介导)刺激。保守的组氨酸(H)-89位点需要
MBP84-104的细胞内转运和镇痛活性。使用生化和分子工具,包括
质谱学、RNA测序、生物信息学、结构建模和免疫捕获野生型,
突变多肽和对照多肽,结合严格的药理学、神经病理学和行为学
分析,我们发现了一组MBP84-104相互作用因子和下游信号转导因子促进
女性(和/或保护男性免受)痛觉过敏症的发展。这些与MBP84-104相关的销售线索
在痛觉回路中已确定的角色,如X染色体印记基因白介素6,在这里与一种
脂质、免疫和雌激素受体信号通路的主要调节者,肝脏X受体,这是新的
痛苦的领域。凭借我们独特的、累积的工具集和严格的数据,在
PI、Veronica Shubayev(UCSD)、Tony Yaksh(UCSD)和Alex Strongin(SBP)的团队,我们的目标是
确定神经、背根神经节和脊髓中导致性行为的精确分子事件
神经病理性疼痛中的二形性。我们希望我们的创新发现将促进概念上的发展
用于顽固性慢性疼痛的新型止痛疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VERONICA SHUBAYEV其他文献
VERONICA SHUBAYEV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VERONICA SHUBAYEV', 18)}}的其他基金
Proteolysis of Myelin as a Source of Neuropathic Pain
髓磷脂的蛋白水解是神经性疼痛的根源
- 批准号:
8518295 - 财政年份:2012
- 资助金额:
$ 72.32万 - 项目类别:
Proteolysis of Myelin as a Source of Neuropathic Pain
髓磷脂的蛋白水解是神经性疼痛的根源
- 批准号:
9094552 - 财政年份:2012
- 资助金额:
$ 72.32万 - 项目类别:
Proteolysis of Myelin as a Source of Neuropathic Pain
髓磷脂的蛋白水解是神经性疼痛的根源
- 批准号:
8345053 - 财政年份:2012
- 资助金额:
$ 72.32万 - 项目类别:
Proteolysis of Myelin as a Source of Neuropathic Pain
髓磷脂的蛋白水解是神经性疼痛的根源
- 批准号:
9315285 - 财政年份:2012
- 资助金额:
$ 72.32万 - 项目类别:
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases
神经损伤的发病机制:基质金属蛋白酶的作用
- 批准号:
8397543 - 财政年份:2009
- 资助金额:
$ 72.32万 - 项目类别:
Pathogenesis of Nerve Injury: Role of Matrix Metalloproteinases
神经损伤的发病机制:基质金属蛋白酶的作用
- 批准号:
7796957 - 财政年份:2009
- 资助金额:
$ 72.32万 - 项目类别:
Pathogenesis of Nerve Injury: Role of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)
神经损伤的发病机制:金属蛋白酶组织抑制剂 1 (TIMP-1) 的作用
- 批准号:
10000652 - 财政年份:2009
- 资助金额:
$ 72.32万 - 项目类别:
Pathogenesis of Nerve Injury: Role of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)
神经损伤的发病机制:金属蛋白酶组织抑制剂 1 (TIMP-1) 的作用
- 批准号:
10456102 - 财政年份:2009
- 资助金额:
$ 72.32万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 72.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 72.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 72.32万 - 项目类别:














{{item.name}}会员




